World's Best Scientists 2026 revealed!
Keith A. Hawkins

Keith A. Hawkins

D-Index & Metrics

Psychology

D-Index
48
Citations
11770
World Ranking
5859
National Ranking
3179

Overview

Keith A. Hawkins is affiliated with Yale University in the United States and focuses on research within the field of Medicine. Their work spans several subfields, including General Health Professions, Psychiatry and Mental Health, Cognitive Neuroscience, Neurology, and Cardiology and Cardiovascular Medicine.

The scientist's research covers key topics such as Attention Deficit Hyperactivity Disorder, Hermeneutics and Narrative Identity, Aging, Elder Care, and Social Issues, Health, Medicine and Society, Parkinson's Disease Mechanisms and Treatments, Neurological Disorders and Treatments, and Intensive Care Unit Cognitive Disorders.

Selected recent papers by Keith A. Hawkins include:

  • Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease (2020), published in Annals of Clinical and Translational Neurology
  • Depression predicts cognitive and functional decline one month after coronary artery bypass graft surgery (Neuropsychiatric Outcomes After Heart Surgery study) (2020), published in International Journal of Geriatric Psychiatry
  • A randomized clinical trial to evaluate feasibility, tolerability, and preliminary target engagement for a novel executive working memory training in adolescents with ADHD (2024), published in Behaviour Research and Therapy
  • NANCY: Next-generation All-sky Near-infrared Community surveY (2023), published in arXiv (Cornell University)
  • Age-related, multivariate associations between white matter microstructure and behavioral performance in three executive function domains (2023), published in Developmental Cognitive Neuroscience

Their frequent co-authors include:

  • Jacey Anderson
  • Godfrey D. Pearlson
  • Michael C. Stevens
  • Abigail Sullivan
  • Morgan Beatty

Keith A. Hawkins has published multiple articles in several venues, notably:

  • arXiv (Cornell University)
  • Biological Psychiatry
  • Annals of Clinical and Translational Neurology
  • International Journal of Geriatric Psychiatry
  • Behaviour Research and Therapy

The research contributions of Keith A. Hawkins predominantly engage with clinical and neurological aspects of medical science, underlining investigations into cognitive and psychiatric effects related to neurodegenerative diseases and cardiovascular conditions, as well as interventions in neurodevelopmental disorders such as ADHD.

Best Publications

  • The Parkinson Progression Marker Initiative (PPMI)

    Kenneth Marek;Danna Jennings;Shirley Lasch;Andrew Siderowf

  • Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis.

    Thomas H. McGlashan;Robert B. Zipursky;Diana Perkins;Jean Addington

  • Transcranial magnetic stimulation of left temporoparietal cortex and medication-resistant auditory hallucinations.

    Ralph E. Hoffman;Keith A. Hawkins;Ralitza Gueorguieva;Nash N. Boutros

  • The effects of apolipoprotein E on non-impaired cognitive functioning: A meta-analysis

    Nick M. Wisdom;Jennifer L. Callahan;Jennifer L. Callahan;Keith A. Hawkins

  • Neuropsychology of the Prodrome to Psychosis in the NAPLS Consortium: Relationship to Family History and Conversion to Psychosis

    Larry J. Seidman;Anthony J. Giuliano;Eric C. Meyer;Jean Addington

  • Association of Cerebrospinal Fluid β-Amyloid 1-42, T-tau, P-tau181, and α-Synuclein Levels With Clinical Features of Drug-Naive Patients With Early Parkinson Disease

    Ju-Hee Kang;Ju-Hee Kang;David J. Irwin;Alice S. Chen-Plotkin;Andrew Siderowf

  • Temporoparietal Transcranial Magnetic Stimulation for Auditory Hallucinations: Safety, Efficacy and Moderators in a Fifty Patient Sample

    Ralph E. Hoffman;Ralitza Gueorguieva;Keith A. Hawkins;Maxine Varanko

  • Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease

    Daniel Weintraub;Tanya Simuni;Chelsea Caspell-Garcia;Christopher Coffey

  • The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design.

    T. H. McGlashan;R. B. Zipursky;D. Perkins;J. Addington

  • Endophenotypes in schizophrenia: a selective review.

    Allyssa J. Allen;Mélina E. Griss;Bradley S. Folley;Keith A. Hawkins

  • Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome

    Scott W Woods;Alan Breier;Robert B Zipursky;Diana O Perkins

  • Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome Study.

    Andrew Siderowf;Danna Jennings;Shirley Eberly;David Oakes

  • Incidence of tardive dyskinesia with atypical versus conventional antipsychotic medications: a prospective cohort study.

    Scott W. Woods;Hal Morgenstern;John R. Saksa;Barbara C. Walsh

  • Neuropsychological status of subjects at high risk for a first episode of psychosis

    K. A. Hawkins;J. Addington;R. S E Keefe;B. Christensen

  • A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users.

    Arthur Margolin;S. Kelly Avants;Lara A. Warburton;Keith A. Hawkins

  • The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sample.

    T. J. Miller;R. B. Zipursky;D. Perkins;J. Addington

  • Probing the Pathophysiology of Auditory/Verbal Hallucinations by Combining Functional Magnetic Resonance Imaging and Transcranial Magnetic Stimulation

    Ralph E. Hoffman;Michelle Hampson;Kun Wu;Adam W. Anderson

  • Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia.

    Esperanza Diaz;Heidi B. Levine;Michelle C. Sullivan;Michael J. Sernyak

  • Working memory, attention, and communication disturbances in schizophrenia.

    Nancy M. Docherty;Keith A. Hawkins;Ralph E. Hoffman;Donald M. Quinlan

  • Will the novel antipsychotics significantly ameliorate neuropsychological deficits and improve adaptive functioning in schizophrenia

    K. A. Hawkins;S. Mohamed;S. W. Woods

Frequent Co-Authors

Scott W. Woods
Scott W. Woods Yale University
Ralph E. Hoffman
Ralph E. Hoffman Yale University
Diana O. Perkins
Diana O. Perkins University of North Carolina at Chapel Hill
Mauricio Tohen
Mauricio Tohen University of New Mexico
Dag Aarsland
Dag Aarsland King's College London
Donald M. Quinlan
Donald M. Quinlan Yale University
Howard Tennen
Howard Tennen University of Connecticut
Jennifer L. Callahan
Jennifer L. Callahan University of North Texas
Bruce K. Christensen
Bruce K. Christensen Australian National University
Irene Litvan
Irene Litvan University of California, San Diego

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Psychology students in the USA have diverse online degree options and career directions. Many choose pathways that prepare them for licensure and clinical work, such as counseling or speech therapy. Each state has its own unique requirements and processes for credentialing.

For example, those interested in counseling careers should review lpc licensure requirements in Wyoming, which cover education, supervised hours, and exams. Similarly, speech-language pathology is a popular route requiring specialized training. Information about becoming a speech therapist in Alabama outlines state-specific steps like degree completion and clinical experience.

Requirements may differ considerably by region. For those considering Alaska, how to become a speech language pathologist in Alaska details local licensing processes. Similarly, slp requirements in Arizona discuss educational prerequisites and supervised practice hours.

Before choosing a degree or career pathway, it’s crucial to explore your state's specific requirements. This ensures you gain the proper certifications and are well-prepared for future opportunities in the psychology field.

Best Scientists Citing Keith A. Hawkins

Trending Scientists